{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:14:14Z","timestamp":1777065254804,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clinbiochem.2026.111098","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:01:47Z","timestamp":1770969707000},"page":"111098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC)"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-9320","authenticated-orcid":false,"given":"Victoria","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipin","family":"Bhayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald A.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola Z.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Macri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig S.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Newbigging","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Olayinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Poliakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Rodriguez-Capote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Thebault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Beriault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.clinbiochem.2026.111098_b0005","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111098_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0015","unstructured":"Atlas of MS 3rd Edition. MS International Federation; 2020."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111098_b0020","first-page":"37","article-title":"Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts","volume":"37","author":"Amankwah","year":"2017","journal-title":"Health Promot Chronic Dis Prev Can Res Policy Pract."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111098_b0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111098_b0035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch. Neurol."},{"issue":"Suppl 2","key":"10.1016\/j.clinbiochem.2026.111098_b0040","first-page":"217","article-title":"Cerebrospinal fluid analysis and the determination of oligoclonal bands","volume":"38","author":"Gastaldi","year":"2017","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clinbiochem.2023.04.006","article-title":"Variation in processes and reporting of cerebrospinal fluid oligoclonal banding and associated tests and calculated indices across Canadian clinical laboratories","volume":"116","author":"Higgins","year":"2023","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2024.110855","article-title":"A survey of Canadian neurologists\u2019 perspectives and preferences for laboratory reporting of CSF oligoclonal banding","volume":"135","author":"Higgins","year":"2025","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0055","first-page":"1","article-title":"A review of laboratory practices for CSF oligoclonal banding and associated tests","volume":"20","author":"Higgins","year":"2025","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0060","unstructured":"L. Olayinka, Y. Chen, K. Rodriguez-Capote, J. Gifford, C. Buch, S. Weber, et al. Oligoclonal banding analysis: Assessing plasma use and time interval requirements for paired CSF and blood. Submitted for publication."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0065","unstructured":"S. Thebault, R. Booth. Diagnostic Performance and Reproducibility of Cerebrospinal Fluid Oligoclonal Band Number in Multiple Sclerosis. [Manuscript in Preparation]. 2025."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111098_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111098_b0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0269216317690685","article-title":"Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: recommendations based on a methodological systematic review","volume":"31","author":"J\u00fcnger","year":"2017","journal-title":"Palliat. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111098_b0080","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1515\/cclm-2020-1037","article-title":"Inter-center agreement in the interpretation of oligoclonal bands","volume":"59","author":"Mariotto","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111098_b0085","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s00415-005-0820-1","article-title":"Clinical correlations of CSF single IgG bands","volume":"252","author":"Franciotta","year":"2005","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111098_b0090","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1373\/clinchem.2007.089052","article-title":"Interlaboratory reproducibility of isoelectric focusing in oligoclonal band detection","volume":"53","author":"Franciotta","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0095","unstructured":"SPIFE\u00ae Touch IgG IEF Procedure, Cat No. 3389. Helena Laboratories."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0100","unstructured":"HYDRAGEL 3 CSF ISOFOCUSING Ref. 4353 & HYDRAGEL 9 CSF ISOFOCUSING Ref. 4355. Sebia."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111098_b0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/labmed\/lmac126","article-title":"The interpretation of mirror pattern bands during oligoclonal immunoglobulin isoelectric focusing electrophoresis: aretrospective study","volume":"54","author":"Wang","year":"2023","journal-title":"Lab. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111098_b0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1373\/jalm.2018.026088","article-title":"Laboratory performance on reporting monoclonal gammopathy during cerebrospinal fluid oligoclonal banding analysis from external quality assessment surveys","volume":"3","author":"Chen","year":"2018","journal-title":"J. Appl. Lab. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111098_b0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10408363.2022.2039591","article-title":"Oligoclonal bands: clinical utility and interpretation cues","volume":"59","author":"Carta","year":"2022","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2026.111098_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2009.09.002","article-title":"Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis","volume":"219","author":"Awad","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111098_b0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1590\/0004-282x20160066","article-title":"Knowledge-base for interpretation of cerebrospinal fluid data patterns. Essentials in neurology and psychiatry","volume":"74","author":"Reiber","year":"2016","journal-title":"Arq. Neuropsiquiatr."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111098_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0135","series-title":"Laboratory Diagnosis in Neurology","author":"Wildemann","year":"2010"},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111098_b0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1515\/labm.1997.21.5.275","article-title":"Interpretation of CSF quantities with the knowledge-based system Pro.M.D.-cerebrospinal fluid diagnostics","volume":"21","author":"Faber","year":"1997","journal-title":"LaboratoriumsMedizin"},{"issue":"8","key":"10.1016\/j.clinbiochem.2026.111098_b0145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111098_b0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111098_b0155","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria.","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111098_b0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111098_b0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","article-title":"Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force","volume":"13","author":"Deisenhammer","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111098_b0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1474-4422(13)70233-3","article-title":"Body fluid biomarkers in multiple sclerosis","volume":"13","author":"Comabella","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0175","unstructured":"Cerebrospinal Fluid Chemistry and Oligoclonal Bands M-A 2024 Participant Summary. College of American Pathologists; 2024."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111098_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215410","article-title":"The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing. A retrospective study and systematic review","volume":"14","author":"Hegen","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111098_b0185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"Stangel","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111098_b0190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.21037\/atm-21-3073","article-title":"Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review","volume":"11","author":"Jin","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0195","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fneur.2019.00584","article-title":"The influence of blood contamination on cerebrospinal fluid diagnostics","volume":"10","author":"Schwenkenbecher","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105905","article-title":"Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis","volume":"120","author":"Deisenhammer","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clinbiochem.2026.111098_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111098_b0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","article-title":"Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis","volume":"80","author":"Meier","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clinbiochem.2026.111098_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102870","article-title":"A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: a systematic review and meta-analysis","volume":"51","author":"Sun","year":"2021","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:07:59Z","timestamp":1773277679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":43,"alternative-id":["S0009912026000263"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111098","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC)","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"111098"}}